AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,178,867 | +147920.9% | 30,321 | +27.0% | 0.03% | +13.0% |
| Q1 2023 | $1,472 | -99.8% | 23,868 | +16.0% | 0.02% | +15.0% |
| Q3 2022 | $918,000 | -45.4% | 20,580 | -53.1% | 0.02% | -54.5% |
| Q2 2022 | $1,680,000 | -47.9% | 43,862 | -43.7% | 0.04% | -42.1% |
| Q1 2022 | $3,227,000 | +92.9% | 77,967 | +76.1% | 0.08% | +171.4% |
| Q4 2021 | $1,673,000 | -43.8% | 44,274 | -51.0% | 0.03% | -41.7% |
| Q3 2021 | $2,977,000 | +65.5% | 90,329 | +238.8% | 0.05% | +41.2% |
| Q2 2021 | $1,799,000 | -26.7% | 26,661 | -38.5% | 0.03% | -30.6% |
| Q1 2021 | $2,453,000 | +583.3% | 43,328 | +884.1% | 0.05% | +390.0% |
| Q4 2020 | $359,000 | -62.3% | 4,403 | -67.1% | 0.01% | -75.6% |
| Q3 2020 | $953,000 | +81.5% | 13,381 | +109.8% | 0.04% | +57.7% |
| Q2 2020 | $525,000 | -78.4% | 6,379 | -72.8% | 0.03% | -76.1% |
| Q4 2019 | $2,426,000 | – | 23,473 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |